The GEP100/AMAP1 'Homo' group, in which expressions of GEP100 and AMAP1 both belong to the high-expression groups, also shows a statistically shorter time to events after HNSCC resection than the 'Others', in which either one of the GEP100 expression or the AMAP1 expression, or both belong to the low-expression groups (p = 0.03615 for the disease-free survival and p < 0.001 for the overall survival, Figure 3G and H). Here, ASAP1 is linked to head and neck squamous cell carcinoma.